Pfizer Ltd
NSE:PFIZER

Watchlist Manager
Pfizer Ltd Logo
Pfizer Ltd
NSE:PFIZER
Watchlist
Price: 5 097.6 INR -0.06% Market Closed
Market Cap: 233.2B INR

Relative Value

The Relative Value of one PFIZER stock under the Base Case scenario is hidden INR. Compared to the current market price of 5 097.6 INR, Pfizer Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PFIZER Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
17
Median 3Y
9.3
Median 5Y
9.2
Industry
2.6
Forward
9.4
vs History
85
vs Industry
15
Median 3Y
32.8
Median 5Y
34.7
Industry
21.7
Forward
31
vs History
96
vs Industry
9
Median 3Y
48.6
Median 5Y
48.3
Industry
16.7
vs History
96
vs Industry
10
Median 3Y
66.7
Median 5Y
62
Industry
23.1
vs History
61
vs Industry
14
Median 3Y
5.9
Median 5Y
6.5
Industry
2.2
vs History
36
vs Industry
18
Median 3Y
8.3
Median 5Y
8.4
Industry
2.9
Forward
8.3
vs History
44
vs Industry
18
Median 3Y
12.9
Median 5Y
13.2
Industry
5.5
vs History
55
vs Industry
16
Median 3Y
25.7
Median 5Y
26.4
Industry
13.2
Forward
24
vs History
65
vs Industry
18
Median 3Y
28.5
Median 5Y
28.8
Industry
16.8
Forward
23
vs History
96
vs Industry
10
Median 3Y
43.6
Median 5Y
43.6
Industry
15.9
vs History
96
vs Industry
12
Median 3Y
52.9
Median 5Y
48.4
Industry
19.2
vs History
22
vs Industry
10
Median 3Y
9.5
Median 5Y
10.3
Industry
1.9

Multiples Across Competitors

PFIZER Competitors Multiples
Pfizer Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Pfizer Ltd
NSE:PFIZER
233.2B INR 9.8 27.8 25.4 27.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 17 54.9 36.9 39.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
501.5B USD 5.4 20 16.3 21.2
CH
Roche Holding AG
SIX:ROG
259.2B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212.4B GBP 4.9 30.2 108.5 158.7
CH
Novartis AG
SIX:NOVN
207B CHF 4.7 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
253.9B USD 4 13.3 9.5 11.3
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
144.5B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
IN
Pfizer Ltd
NSE:PFIZER
Average P/E: 24.4
27.8
9%
3.1
US
Eli Lilly and Co
NYSE:LLY
54.9
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.3
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Pfizer Ltd
NSE:PFIZER
Average EV/EBITDA: 401.3
25.4
13%
2
US
Eli Lilly and Co
NYSE:LLY
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.5
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.5
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Pfizer Ltd
NSE:PFIZER
Average EV/EBIT: 1 712.8
27.4
13%
2.1
US
Eli Lilly and Co
NYSE:LLY
39.5
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.2
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.3
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3